NEW YORK (GenomeWeb News) – Several UK government bodies plan to award up to £3.8 million ($6.1 million) in competitive grants to fund industry-led research and development projects to advance synthetic biology technologies, according to the Biotechnology and Biological Sciences Research Council.

The funding from the BBSRC, the Technology Strategy Board, the Engineering and Physical Sciences Research Council, and the Welsh government, is part of a planned large-scale push by the UK to make it an international player in applied synthetic biology industries.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

An opinion piece in the Guardian argues that President Donald Trump is uninterested in science and that might not be a bad thing for the field.

The San Francisco Chronicle reports the Veterans Affairs Health System is studying whether genetic testing can help prescribe better depression therapies.

Stat News reports that Spark Therapeutics' Luxturna is now being used to treat a wider array of patients.

In Genome Biology this week: transcription factor use among brittle stars, single-cell RNA sequencing strategy, and more.